Stock Price
32.76
Daily Change
-0.52 -1.56%
Monthly
-8.06%
Yearly
2.89%
Q1 Forecast
31.16

Veracyte reported $4.59M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Agilent USD 602M 32M Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Bruker USD 215.9M 31.5M Dec/2025
Exact Sciences USD 175.87M 46.51M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Illumina USD 240M 22M Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Laboratory Of America USD 840.8M 172.3M Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
Myriad Genetics USD 30M 1.8M Dec/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Siemens EUR 8.57B 611M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
Veracyte USD 4.59M 916K Dec/2025
Waters USD 103.78M 11.95M Dec/2025